Τίτλος:
Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Introduction: The safety of upper gastrointestinal cancer patients in the SARS-CoV-2 outbreak is extremely important and most surgeons need to establish a contingency management. Aim: In this study, we present the surgical outlines of patients suffering from upper gastrointestinal cancers. Materials and Methods: Data were obtained from PubMed, Cochrane Database of Controlled Trials, and SCOPUS of reports up to September 2020. Results: The COVID-19 outbreak makes surgical procedures extremely difficult to be performed. The most common criteria to prioritize patients for surgical treatment are stage, tumor biology, presence of tumor-related symptoms, the risk of tumor to become non-resectable, and time interval from neoadjuvant therapy. The multidisciplinary teams can help assigning a priority level to each clinical case. Conclusion: We have to continue providing treatment to oncologic patients in the face of COVID-19 uncertainty, with higher caution and responsibility in order to develop a safer and more effective personalized treatment plan. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Συγγραφείς:
Apostolou, K.
Vogli, S.
Frountzas, M.
Syllaios, A.
Tolia, M.
Papanikolaou, I.S.
Schizas, D.
Περιοδικό:
Journal of Gastrointestinal Cancer
Λέξεις-κλειδιά:
algorithm; cancer diagnosis; cancer patient; cancer staging; cancer surgery; clinical outcome; coronavirus disease 2019; COVID-19 testing; digestive system cancer; gastrointestinal endoscopy; human; infection risk; multidisciplinary team; neoadjuvant therapy; nonhuman; pandemic; priority journal; Review; Severe acute respiratory syndrome coronavirus 2; surgical technique; time factor; treatment planning; upper gastrointestinal tract; complication; epidemiology; etiology; gastrointestinal tumor; risk factor; upper gastrointestinal tract, Algorithms; COVID-19; Endoscopy, Gastrointestinal; Gastrointestinal Neoplasms; Humans; Risk Factors; SARS-CoV-2; Upper Gastrointestinal Tract
DOI:
10.1007/s12029-020-00557-y
